Uplyso alfataliglicerase regulatory update

Protalix said the Mexican Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) and the Public Health Institute of Chile approved Uplyso alfataliglicerase for long-term enzyme replacement therapy in adults with Type I Gaucher's disease. In May 2012, FDA approved the plant cell-expressed recombinant form of human glucocerebrosidase under the name Elelyso taliglucerase alfa. The product is also approved in Brazil and Israel. ...